Xencor market cap XNCR

Share price times shares outstanding: what the whole company sells for, since 2014.

Xencor is worth $1.9B at the close on Oct 23, 2026, at $25.18 a share.

That is up 99% over the last year and down 19% over five years.

Its highest close in our data was $3B in Feb 2021.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$1.9B	$814.8M	$2.1B	+72%
2025	$1.1B	$515.7M	$1.7B	−36%
2024	$1.7B	$991.8M	$1.8B	+32%
2023	$1.3B	$1B	$2.2B	−17%
2022	$1.6B	$1.2B	$2.2B	−33%
2021	$2.3B	$1.8B	$3B	−6%
2020	$2.5B	$1.5B	$2.6B	+25%
2019	$2B	$1.6B	$2.5B	+3%
2018	$2B	$1B	$2.7B	+90%
2017	$1B	$894.4M	$1.2B	−5%
2016	$1.1B	$433.5M	$1.1B	+83%
2015	$591.8M	$438.3M	$988.4M	+13%
2014	$523.4M	$252.1M	$523.4M	n/a

Companies in Drug Manufacturers - General nearest Xencor's size, closest first, today.

Company	Market cap
XNCRXencor	$1.9B
ANIPANI Pharmaceuticals	$1.7B
HRMYHarmony Biosciences	$2.1B
PAHCPhibro Animal Health	$1.6B
PBHPrestige Consumer Healthcare	$2.3B
ANABAnaptysbio	$1.5B
PCRXPacira BioSciences	$1.5B
NRIXNurix Therapeutics	$2.8B
OMEROmeros	$1.2B
AMPHAmphastar Pharmaceuticals	$1.1B
OGNOrganon	$3.6B
Peer median	$1.6B